ChronoScale Holdings Corp
ChronoScale Holdings Corp is a U.S.-based medical robotics company focused on wearable robotic exoskeletons for rehabilitation and mobility support. Its business centers on the EksoNR, Ekso Indego Therapy, and Ekso Indego Personal device families, along with related services such as warranty coverage, repairs, and training.
Tilikausi 2026 · muutos edellisvuodesta
Kehitys 2021–2026
Liiketoiminta
Osuus liikevaihdostaRobotic exoskeletons sold or subscribed for clinical rehabilitation use in healthcare facilities.
Wearable exoskeletons used by individuals for personal mobility and rehabilitation support.
Device access arrangements sold through finance partners or subscription structures.
Fee-based repair, maintenance, and loaner-device services for installed products.
Online and in-person training, clinical support, and portal-based device services.
Asiakkaat
The company sells primarily to healthcare providers and distributors that serve rehabilitation and mobility markets. In Enterprise Health, buyers include inpatient rehabilitation facilities, long-term acute care hospitals, skilled nursing facilities, outpatient clinics, and integrated delivery networks. In Personal Health, customers include end users and the financing partners that facilitate subscription-style access to devices.
Hospitals, IRFs, LTACHs, SNFs, and outpatient clinics buy EksoNR and Ekso Indego Therapy for rehabilitation programs.
Large provider networks buy multi-unit systems to standardize rehabilitation workflows and improve purchasing economics.
Independent distributors buy and resell products in parts of EMEA and APAC, especially outside direct-sales markets.
Individuals and their care channels buy Ekso Indego Personal for mobility and rehabilitation support.
Third-party financing partners purchase devices in subscription structures and contract with end customers.
Strategia
The company is focused on expanding adoption of its rehabilitation and personal mobility products through clinical education, reimbursement coverage, and broader indications of use. It also uses service, training, and subscription structures to make adoption easier for customers with different capital budgets. The product roadmap includes new offerings such as Nomad, while distribution and strategic review activity add optionality to the business model.
Coverage determines affordability and adoption for Personal Health devices.
Enterprise Health sales depend on evidence, stakeholder education, and workflow fit.
New devices can extend the addressable market and support future growth.
A strategic transaction could reshape the business or unlock value.
Maantiede
Q1/2026The company sells across the Americas, EMEA, and APAC, with direct sales in the Americas and a mix of direct and distributor-led channels elsewhere. German-speaking countries in Europe are handled directly, while many other European and APAC markets rely on distributors, making channel execution important to growth. Foreign markets also require country-specific regulatory approvals and compliance, which affects where products can be marketed and how quickly they can scale.
Osuus liikevaihdosta, jonka yhtiö raportoi maantieteellisesti.
Riskit
The business depends on regulatory approvals, reimbursement coverage, and adoption of a relatively early-stage technology, so commercialization can be uneven. It also relies on distributors in several markets, which creates channel concentration and compliance risk, while competition and product-development execution remain important in a fast-changing medical robotics field.
- Regulatory approval riskVaikutus: KorkeaTodennäköisyys: Korkea
Products must clear country-specific approval and compliance requirements before sale.
Kohdistuu - Distributor concentrationVaikutus: KorkeaTodennäköisyys: Kohtalainen
Independent distributors are principal customers in several non-direct markets.
Kohdistuu: Non-German Europe and parts of APAC
- Reimbursement and coverage riskVaikutus: KorkeaTodennäköisyys: Kohtalainen
Personal Health growth depends on insurance coverage and reimbursement processes.
Kohdistuu: Personal Health
- Technology and competition riskVaikutus: KeskitasoTodennäköisyys: Kohtalainen
Exoskeleton technology remains early-stage and competitors are developing alternatives.
Kohdistuu: Medical robotics market
- Cybersecurity riskVaikutus: KeskitasoTodennäköisyys: Kohtalainen
The company processes sensitive data and relies on connected systems and vendors.
Kohdistuu: Operations and customer data
Kirjanpito
Harkinnanvaraiset erätDevice sales, subscriptions, training, and support may be bundled and recognized differently over time.
Vaikutus: Affects timing and mix of reported revenue
EksoCare and device warranties require estimates of future repair and support obligations.
Vaikutus: Affects gross margin and accrued liabilities
Valuation uses unobservable inputs and can create non-cash gains or losses.
Vaikutus: Affects other income/expense and equity
Specialized hardware can become obsolete or require write-downs if demand changes.
Vaikutus: Affects gross profit and working capital
Loss history makes realizability judgments important.
Vaikutus: Affects tax assets and net income
Facility and equipment leases affect balance sheet liabilities and operating expense presentation.
Vaikutus: Affects leverage and operating costs
Samankaltaisia listattuja yhtiöitä
Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.
Myomo Inc
MYO · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Lifeward Ltd.
LFWD · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Hinge Health, Inc.
HNGE · Services-Computer Processing & Data Preparation
enVVeno Medical Corp
NVNO · Surgical & Medical Instruments & Apparatus
enVVeno Medical Corp is a U.S.-based medical device company focused on developing bioprosthetic venous valve technologies for severe chronic venous insufficiency.
Alphatec Holdings, Inc.
ATEC · Surgical & Medical Instruments & Apparatus
ExlService Holdings, Inc.
EXLS · Services-Business Services, NEC
Päivitetty: 24.9.2026